Glioblastoma Clinical Trials in Baltimore, MD

Glioblastoma Clinical Trials in Baltimore, MD

View the best 10 glioblastoma medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Baltimore, Maryland

Here are the top 10 medical studies for glioblastoma in Baltimore, Maryland

Image of Children's Hospital of Alabama in Birmingham, United States.

Ensartinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 genomic alterations.
Image of University of California, San Diego Rady Children's Hospital in San Diego, United States.

Specialized tumor board recommendation

Molecular Profiling

Recruiting1 award9 criteria
This trial will test a new treatment approach for children with High-grade gliomas HGG that is based on each patient's tumor gene expression, whole-exome sequencing (WES), targeted panel profile (UCSF 500 gene panel), and RNA-Seq.
Image of Rady Children's Hospital in San Diego, United States.

Fimepinostat

Histone Deacetylase (HDAC) Inhibitor

Recruiting1 awardPhase < 1
This trial is testing how well fimepinostat works in treating patients with newly diagnosed brain tumors. Fimepinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of National Institutes of Health Clinical Center in Bethesda, United States.

Nivolumab

PD-1 Inhibitor

Recruiting1 awardPhase 2
This trial is testing nivolumab to see if it stops tumor growth and prolongs the time that the tumor is controlled in adults with IDH1 or IDH2 mutated gliomas.
Image of Children's Hospital of Alabama in Birmingham, United States.

Selinexor

Selective Inhibitor of Nuclear Export (SINE)

Recruiting1 awardPhase 1
This trial studies selinexor to learn if it can help to shrink tumors in young patients with solid tumors or CNS tumors.
Image of Investigation Site in Newark, United States.

IGV-001 +2 More

Cell Immunotherapy

Recruiting0 awardsPhase 2
This trial will compare a new treatment for glioblastoma to placebo to see if it extends survival.
Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a combination of therapies to see if they're more effective than radiation therapy alone in treating recurrent glioblastoma.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

BPM31510

Recruiting1 awardPhase 2
This trial will study the effects of adding a new drug, BPM31510, to standard radiation and chemotherapy treatment for newly diagnosed glioblastoma patients.

Popular filter options for glioblastoma baltimore trials

Clinical Trials With No Placebo

View 65 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.